Actavis, Inc. News Headlines

ACT 
$218.68
*  
0.95
0.43%
Get ACT Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ACT After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dan Loeb’s Third Point Partners buys a position in CF Industries
5/23/2014 9:00:00 AM - Market Realist

Dan Loeb’s Third Point Partners buys a large stake in Actavis
5/22/2014 4:20:00 PM - Market Realist

Dan Loeb’s Third Point Partners: Key positions in 1Q 2014
5/22/2014 12:19:00 PM - Market Realist

Valeant: Poor Earnings Quality Masked By Acquisition Related Pro-Forma Reporting
5/21/2014 6:08:00 PM - Seeking Alpha

Celgene Asserts More Revlimid Patents, Seeks New Ones To 2031
5/20/2014 6:07:00 PM - Seeking Alpha

Tracking Carl Icahn's Portfolio - Q1 2014 Update
5/20/2014 1:46:00 AM - Seeking Alpha

MYOS Appoints Joseph DosSantos As CFO - Quick Facts
5/19/2014 8:04:00 AM - RTT News

Legal Setback for Eli Lilly in the UK - Analyst Blog
5/16/2014 4:10:00 PM - Zacks.com

J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market
5/16/2014 9:17:00 AM - Seeking Alpha

Thoughts On The Celgene Revlimid Markman Hearing
5/16/2014 9:15:00 AM - Seeking Alpha

Third Point Adds New Stakes in American Airlines, Anheuser-Busch
5/15/2014 5:33:00 PM - Dow Jones Business News

Actavis Reaches Agreement With Janssen On Concerta - Quick Facts
5/15/2014 9:00:00 AM - RTT News

U.S. Hot Stocks: Hot Stocks to Watch
5/15/2014 8:32:00 AM - Dow Jones Business News

Actavis Says Forest Labs' Saunders To Be CEO Of Combined Company
5/14/2014 10:06:00 AM - RTT News

Forest Labs' Saunders to Head Actavis After Deal
5/14/2014 9:25:00 AM - Dow Jones Business News

Why Pfizer’s proposed AstraZeneca takeover is tax-driven
5/14/2014 9:00:00 AM - Market Realist

Actavis Plans New Leadership Team Post Forest Labs. Acquisition - Quick Facts
5/14/2014 8:36:00 AM - RTT News

Actavis Announces Approval For Generic Version Of Exalgo - Quick Facts
5/13/2014 5:15:00 PM - RTT News

The case for Pfizer’s proposed takeover of AstraZeneca
5/13/2014 1:06:00 PM - Market Realist

SSO, ACE, ACT, ADBE: Large Outflows Detected at ETF
5/13/2014 11:00:07 AM - BNK Invest

Wall Street Stays Optimistic Despite Record Run
5/13/2014 6:30:00 AM - RTT News

Valeant Pharma Enters Into Patent Settlement Agreements With Actavis
5/12/2014 5:23:00 PM - RTT News

Actavis Settles Patent Litigation Related To Its Generic Version Of Acanya
5/12/2014 8:18:00 AM - RTT News

Vivus Discloses Competitive Threat
5/10/2014 10:51:00 AM - Seeking Alpha

Acorda Misses on Earnings, Beats Revs - Analyst Blog
5/7/2014 1:43:01 PM - Zacks.com